Citing the latest Cochrane review, the University of Massachusetts Amherst reported that nicotine e-cigarettes are more effective smoking cessation products than traditional nicotine replacement therapy (NRT). The review found high-certainty evidence that e-cigarettes are more likely to lead to cessation from cigarettes than using patches, gum, lozenges or other traditional NRT.
Jamie Hartman-Boyce, a professor at the University of Massachusetts Amherst, said: “In contrast to other parts of the world, in the UK public health agencies have embraced e-cigarettes as a way to help people reduce the harms of smoking. Tools. Most adults who smoke in the United States want to quit, but many find it difficult to do so.”
It is understood that the review included 88 studies with more than 27,235 participants, most of which were conducted in the United States, United Kingdom or Italy. “We have very clear evidence that, although not zero risk, nicotine e-cigarettes are far less harmful than smoking (rolled) cigarettes,” Hartmann-Boyce said. “Some people who have used other smoking cessation aids in the past without success have found that E-cigarettes work.”
Research shows that for every 100 people who use nicotine e-cigarettes to quit smoking, it is expected that 8 to 10 people will successfully quit smoking, compared with only 6 out of 100 people using traditional nicotine replacement therapy, and this is not possible without any support or only through behavior. 4 out of 100 people who try to quit smoking with support successfully quit.
However, the US FDA has not yet approved any e-cigarettes as a drug to help adults quit smoking. “While some e-cigarettes can help adult smokers completely stay away from or significantly reduce their use of more harmful combustible cigarettes, the law’s public health standards balance this potential with youth exposure to these highly addictive products,” said FDA Commissioner Robert Califf. Known and unknown risks with respect to attraction, absorption and use.”
Post time: Jan-12-2024
